Search results for

In the aftermath of the Glivec decision, multinational pharmaceutical companies are concerned about the status of the patent protection in India and are issuing dire warnings about impediments to drug development. Is there really cause for worry?

The European Commission cunningly kept at least one card up its sleeve when it circulated the draft proposals for reforming the Trade Marks Directive and CTM Regulation last month

A new report from the Australian government says that TRIPs and FTA-mandated patent term extensions may not benefit the country

In an interview conducted during last month’s US Patent Forum, former chief judge of the Federal Circuit Paul Michel talked about Congress, the Supreme Court and patent reform

The Shield Act is "entirely unnecessary"; the America Invents Act was a missed opportunity; and two recent US Supreme Court decisions were "extremely poorly reasoned and very harmful to a well-functioning system"

A former official who helped draft the second and third revisions of the Chinese Patent Law has said that proposals to revise the law a fourth time include some “potentially problematic” changes

It was a great pleasure to present an outstanding achievement award to Jeremy Phillips at our Global Awards Dinner this week

Back in 2008, Lisa Pearson of Kilpatrick Townsend & Stockton in New York wrote an article for us on what she saw as an emerging trend: the increasingly dynamic use of trade marks, with brands not just evolving but deliberately distorting their key features to retain their appeal online. She called them fluid marks.

Straightforward application of the law But ruling stokes fear among patent owners Section 3(d) needs more clarification The Indian Supreme Court's denial of Novartis's Glivec patent last month prompted dire warnings about patent protection in India, but practitioners warn the ruling should not be taken out of context: it was relatively straightforward application of the law.

China’s remuneration requirements for employee-inventors can cause trouble for unwary employers. Catherine Zheng explains how to avoid problems arising from employee-created intellectual property